
LOW INCIDENCE OF BCR-ABL TRANSCRIPTS IN
ESSENTIAL THROMBOCYTHEMIA
Panovska I, Pavkovic M, Cevreska L, Efremov DG* *Corresponding Author: Dimitar G. Efremov, M.D., Ph.D., Associate Professor of Medicine, Department of Hematology, Faculty of Medicine, Vodnjanska 17, 1000 Skopje, Republic of Macedonia; Tel: +389-2-147775; Fax: +389-2-110548; E-mail: defremov@mt.net.mk
page: 17
|
REFERENCES
1. Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981; 58: 916-919.
2. Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 1986; 23: 177-182.
3. Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997; 34: 29-39.
4. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290-293.
5. Cortes JE, Talpaz M, Kantarjian H. Chronic myelogenous leukaemia: a review. Am J Med 1996; 100: 555-570.
6. Blickstein D, Aviram A, Luboshitz J, Prokocimer M, Stark P, Bairey O, Sulkes J, Shaklai M. BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients: clinical presentation. Blood 1997; 90: 2768-2771.
7. Singer IO, Sproul A, Tait RC, Soutar R, Gibson B. BCR-ABL transcripts are detectable in all myeloproliferative states. Blood. 1998; 92: 427a.
8. Aviram A, Blickstein D, Stark P, Luboshitz J, Bairey O, Prokocimer M, Shaklai M. Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients. Leuk Lymphoma 1999; 33: 77-82.
9. Yamada H, Murakami T, Kaneda T, Tadachi M, Utsumi M, Minami S, Hamaguchi M, Kasai M, Kodera Y, Ohashi H, Morishita Y, Terasawa T, Yamasaki Y, Kamiya Y, Hattori M, Yamanaka K, Tsushita K, Shimoyama M. Clinical significance of major and minor bcr/abl chimeric transcripts in essential thrombocythemia. Jpn J Clin Oncol 2000; 30: 472-477.
10. Marasca R, Luppi M, Zucchini P, Longo G, Torelli G, Emilia G. Might essential thrombocythemia carry Ph anomaly? Blood 1998; 91: 3084-3085.
11. Sole F, Florensa L, Espinet B, Besses C, Lloveras E, Woessner S. Absence of bcr/abl rearrangement in 41 patients with essential thrombocythemia. Haematologica 2000; 85: 214-215.
12. Heller P, Kornblihtt LI, Cuello MT, Larripa I, Najfeld V, Molinas FC. BCR-ABL transcripts may be detected in essential thrombocythemia but lack clinical significance. Blood 2001; 98: 1990-1991.
13. Emilia G, Marasca R, Zucchini P, Temperani P, Luppi M, Torelli G, Lanza F, De Angelis C, Gandini D, Castoldi GL, Vallisa D, Cavanna L, del Senno L. BCR-ABL rearrangement is not detectable in essential thrombocythemia. Blood 2001; 97: 2187-2189.
14. Damaj G, Delabesse E, Le Bihan C, Asnafi V, Rachid M, Lefrere F, Radford-Weiss I, Macintyre E, Hermine O, Varet B. Typical essential thrombocythaemia does not express bcr-abelson fusion transcript. Br J Haematol. 2002; 116: 812-816.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|